Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

PRP may improve early ACL healing, but long-term effects are unclear.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Platelet- and marrow-derived biologics help heal tissues and reduce infections but need standardized methods for better use.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Itraconazole may cause low platelet and white blood cell counts.

Baricitinib treatment led to dark brown hair regrowth in a red-haired woman with alopecia areata.

The ABHRS has outlined its goals for the next year.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Crisaborole may help regrow hair in children with alopecia areata.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Linagliptin may cause hair loss and skin blisters.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.